Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Change in Account Payables of $592000.0 for Q1 2026, up 226.77% sequentially from -$467000.0 in Q4 2025, and up 238.29% YoY from $175000.0 in Q1 2025.
Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Change in Account Payables for 4 years, with the latest figure at $592000.0 in Q1 2026.
- Quarterly Change in Account Payables rose 238.29% year-over-year to $592000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$611000.0 (up 4.83% YoY) and the FY2025 annual result came in at -$1.0 million, down 711.9% from the prior year.
- Change in Account Payables improved to $592000.0 in Q1 2026 per CAMP's latest filing, from -$467000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.1 million in Q3 2024 and troughed at -$1.0 million in Q2 2024.
- A 4-year average of -$41800.0 and a median of -$170000.0 in 2023 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2026: Change in Account Payables tumbled 470.67% in 2024, then surged 238.29% in 2026.
- Over 4 years, Change in Account Payables stood at -$150000.0 in 2023, then sank by 470.67% to -$856000.0 in 2024, then surged by 45.44% to -$467000.0 in 2025, then surged by 226.77% to $592000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $592000.0, -$467000.0, and -$546000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | 319,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 319,000.00 |
| Jun 30, 2026 | 319,000.00 |
| Mar 31, 2026 | 592,000.00 |
| Mar 31, 2026 | 592,000.00 |
| Dec 31, 2025 | -467,000.00 |
| Dec 31, 2025 | -467,000.00 |
| Sep 30, 2025 | -546,000.00 |
| Sep 30, 2025 | -546,000.00 |
| Jun 30, 2025 | -190,000.00 |
| Jun 30, 2025 | -190,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Dec 31, 2024 | -856,000.00 |
| Dec 31, 2024 | -856,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Mar 31, 2024 | 985,000.00 |
| Mar 31, 2024 | 985,000.00 |